![Allan Wehnert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Allan Wehnert
No open positions remaining
Health Technology
Profile
Allan Wehnert is the founder of Orocidin AS, established in 2023, and holds the title of Chief Executive Officer.
Former jobs include VP-R&D Project Strategy & Portfolio Management at H.
Lundbeck A and Senior Vice President-Clinical, R&D Strategy at Initiator Pharma A.
Allan Wehnert active positions
| Companies | Position | Start |
|---|
Former positions of Allan Wehnert
| Companies | Position | End |
|---|---|---|
| INITIATOR PHARMA A/S | Chief Tech/Sci/R&D Officer | - |
| H. LUNDBECK A/S | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Initiator Pharma A/S
 Initiator Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs to unmet medical needs within the central & peripheral nervous system | Health Technology |
- Stock Market
- Insiders
- Allan Wehnert
